Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials

Publication date: Available online 21 September 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Johannes F E Mann, Thomas Hansen, Thomas Idorn, Lawrence A Leiter, Steven P Marso, Peter Rossing, Jochen Seufert, Sayeh Tadayon, Tina Vilsbøll
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research